Stay updated on Olaparib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Olaparib Plus Pembrolizumab Clinical Trial page
- Check4 days agoChange DetectedThe record history now lists Revision: v3.6.3 as the latest entry, replacing the previous v3.6.2. This reflects a new site revision entry in the page's history.SummaryDifference0.0%

- Check11 days agoChange DetectedNew navigation items and section labels were added to the study record history page, including Compare and sections like Study Design, Study Status, Recruitment Status, Study Identification, IPDSharing, References, and Contacts/Locations, with corresponding version dates.SummaryDifference100%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study has stopped enrolling. A new revision tag (v3.6.0) was added, replacing the previous revision (v3.5.5).SummaryDifference0.1%

- Check33 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, signaling a minor update to the site’s version label.SummaryDifference0.0%

- Check54 days agoChange DetectedFooter Release History now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a newer site maintenance release.SummaryDifference0.0%

- Check75 days agoChange DetectedA new study record version dated **2026-04-22** is added to the record history list, indicating another submission covering study status/identification fields. Alongside this, the page’s displayed system/footer revision changes (e.g., **v3.5.2 → v3.5.3**), which does not represent a change to the trial’s scientific or operational details.SummaryDifference0.2%

Stay in the know with updates to Olaparib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.